Validation: The New Challenge for Pathology

Robert Cardiff, Andrea Rosner, Michael A. Hogarth, Jose J. Galvez, Alexander D Borowsky, Jeffrey Gregg

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Modern pathologists have been challenged to "validate" mouse models of human cancer. Validation requires matching of morphological attributes of the model to human disease. Computers can assist in the validation process. However, adequate controlled, computer-readable vocabularies that can match terms do not currently exist in mouse pathology. Further, current standard diagnostic terminologies do not include the new concepts discussed here such as pathway pathology and mammary intraepithelial neoplasia. The terminologies must be revised and improved to meet the challenge. Human medicine has traditionally used "guilt-by-association" to validate interpretations of disease. Experimental pathology uses experimental verification exemplified by "test-by-transplantation." Genetically Engineered Mice (GEM) develop unique tumor phenotypes bringing new structural-functional insights and reevaluation of concepts. Novel GEM-related tumors appear in all organ systems but mouse models of human breast cancer are prototypes. For example, mammary tumors induced by Mouse Mammary Tumor Virus (MMTV), chemical, radiation or other carcinogenic stimuli have limited phenotypes. These "spontaneous" or induced mammary tumors have never resembled human breast cancers. GEM tumors created with genes associated with human cancer are strikingly different. GEM tumors have unique histological phenotypes. Depending on the genes, the tumors may: 1) resemble MMTV-induced tumors, 2) display "signature" phenotypes, and 3) mimic human breast cancers. The phenotypes can be placed into structural and functional clusters with shared characteristics leading to the concepts of Pathway Pathology: tumor phenotype reflects the genotype.

Original languageEnglish (US)
Pages (from-to)31-39
Number of pages9
JournalToxicologic Pathology
Volume32
Issue numberSUPPL. 1
DOIs
StatePublished - Mar 2004

Fingerprint

Pathology
Tumors
Neoplasms
Phenotype
Breast Neoplasms
Mouse mammary tumor virus
Terminology
Viruses
Genes
Guilt
Vocabulary
Medicine
Breast
Transplantation
Genotype
Radiation
Display devices

Keywords

  • Breast cancer
  • Genetically engineered mice
  • Informatics
  • Mouse models
  • Pathology
  • Validation
  • Vocabulary

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Validation : The New Challenge for Pathology. / Cardiff, Robert; Rosner, Andrea; Hogarth, Michael A.; Galvez, Jose J.; Borowsky, Alexander D; Gregg, Jeffrey.

In: Toxicologic Pathology, Vol. 32, No. SUPPL. 1, 03.2004, p. 31-39.

Research output: Contribution to journalArticle

Cardiff, Robert ; Rosner, Andrea ; Hogarth, Michael A. ; Galvez, Jose J. ; Borowsky, Alexander D ; Gregg, Jeffrey. / Validation : The New Challenge for Pathology. In: Toxicologic Pathology. 2004 ; Vol. 32, No. SUPPL. 1. pp. 31-39.
@article{a7cb35f2d19c4654b4ed5b06d688cc5d,
title = "Validation: The New Challenge for Pathology",
abstract = "Modern pathologists have been challenged to {"}validate{"} mouse models of human cancer. Validation requires matching of morphological attributes of the model to human disease. Computers can assist in the validation process. However, adequate controlled, computer-readable vocabularies that can match terms do not currently exist in mouse pathology. Further, current standard diagnostic terminologies do not include the new concepts discussed here such as pathway pathology and mammary intraepithelial neoplasia. The terminologies must be revised and improved to meet the challenge. Human medicine has traditionally used {"}guilt-by-association{"} to validate interpretations of disease. Experimental pathology uses experimental verification exemplified by {"}test-by-transplantation.{"} Genetically Engineered Mice (GEM) develop unique tumor phenotypes bringing new structural-functional insights and reevaluation of concepts. Novel GEM-related tumors appear in all organ systems but mouse models of human breast cancer are prototypes. For example, mammary tumors induced by Mouse Mammary Tumor Virus (MMTV), chemical, radiation or other carcinogenic stimuli have limited phenotypes. These {"}spontaneous{"} or induced mammary tumors have never resembled human breast cancers. GEM tumors created with genes associated with human cancer are strikingly different. GEM tumors have unique histological phenotypes. Depending on the genes, the tumors may: 1) resemble MMTV-induced tumors, 2) display {"}signature{"} phenotypes, and 3) mimic human breast cancers. The phenotypes can be placed into structural and functional clusters with shared characteristics leading to the concepts of Pathway Pathology: tumor phenotype reflects the genotype.",
keywords = "Breast cancer, Genetically engineered mice, Informatics, Mouse models, Pathology, Validation, Vocabulary",
author = "Robert Cardiff and Andrea Rosner and Hogarth, {Michael A.} and Galvez, {Jose J.} and Borowsky, {Alexander D} and Jeffrey Gregg",
year = "2004",
month = "3",
doi = "10.1080/01926230490424662",
language = "English (US)",
volume = "32",
pages = "31--39",
journal = "Toxicologic Pathology",
issn = "0192-6233",
publisher = "SAGE Publications Inc.",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Validation

T2 - The New Challenge for Pathology

AU - Cardiff, Robert

AU - Rosner, Andrea

AU - Hogarth, Michael A.

AU - Galvez, Jose J.

AU - Borowsky, Alexander D

AU - Gregg, Jeffrey

PY - 2004/3

Y1 - 2004/3

N2 - Modern pathologists have been challenged to "validate" mouse models of human cancer. Validation requires matching of morphological attributes of the model to human disease. Computers can assist in the validation process. However, adequate controlled, computer-readable vocabularies that can match terms do not currently exist in mouse pathology. Further, current standard diagnostic terminologies do not include the new concepts discussed here such as pathway pathology and mammary intraepithelial neoplasia. The terminologies must be revised and improved to meet the challenge. Human medicine has traditionally used "guilt-by-association" to validate interpretations of disease. Experimental pathology uses experimental verification exemplified by "test-by-transplantation." Genetically Engineered Mice (GEM) develop unique tumor phenotypes bringing new structural-functional insights and reevaluation of concepts. Novel GEM-related tumors appear in all organ systems but mouse models of human breast cancer are prototypes. For example, mammary tumors induced by Mouse Mammary Tumor Virus (MMTV), chemical, radiation or other carcinogenic stimuli have limited phenotypes. These "spontaneous" or induced mammary tumors have never resembled human breast cancers. GEM tumors created with genes associated with human cancer are strikingly different. GEM tumors have unique histological phenotypes. Depending on the genes, the tumors may: 1) resemble MMTV-induced tumors, 2) display "signature" phenotypes, and 3) mimic human breast cancers. The phenotypes can be placed into structural and functional clusters with shared characteristics leading to the concepts of Pathway Pathology: tumor phenotype reflects the genotype.

AB - Modern pathologists have been challenged to "validate" mouse models of human cancer. Validation requires matching of morphological attributes of the model to human disease. Computers can assist in the validation process. However, adequate controlled, computer-readable vocabularies that can match terms do not currently exist in mouse pathology. Further, current standard diagnostic terminologies do not include the new concepts discussed here such as pathway pathology and mammary intraepithelial neoplasia. The terminologies must be revised and improved to meet the challenge. Human medicine has traditionally used "guilt-by-association" to validate interpretations of disease. Experimental pathology uses experimental verification exemplified by "test-by-transplantation." Genetically Engineered Mice (GEM) develop unique tumor phenotypes bringing new structural-functional insights and reevaluation of concepts. Novel GEM-related tumors appear in all organ systems but mouse models of human breast cancer are prototypes. For example, mammary tumors induced by Mouse Mammary Tumor Virus (MMTV), chemical, radiation or other carcinogenic stimuli have limited phenotypes. These "spontaneous" or induced mammary tumors have never resembled human breast cancers. GEM tumors created with genes associated with human cancer are strikingly different. GEM tumors have unique histological phenotypes. Depending on the genes, the tumors may: 1) resemble MMTV-induced tumors, 2) display "signature" phenotypes, and 3) mimic human breast cancers. The phenotypes can be placed into structural and functional clusters with shared characteristics leading to the concepts of Pathway Pathology: tumor phenotype reflects the genotype.

KW - Breast cancer

KW - Genetically engineered mice

KW - Informatics

KW - Mouse models

KW - Pathology

KW - Validation

KW - Vocabulary

UR - http://www.scopus.com/inward/record.url?scp=1842510704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842510704&partnerID=8YFLogxK

U2 - 10.1080/01926230490424662

DO - 10.1080/01926230490424662

M3 - Article

C2 - 15209401

AN - SCOPUS:1842510704

VL - 32

SP - 31

EP - 39

JO - Toxicologic Pathology

JF - Toxicologic Pathology

SN - 0192-6233

IS - SUPPL. 1

ER -